SKI Market

Indian Indices

Sensex

79,116.19 -1,122.66
( -1.40%)

Global Indices

Nasdaq

48,521.56 -404.23
(-0.83%)

Dow Jones

6,836.74 -65.88
(-0.95%)

Hang Seng

54,115.64 -2,163.41
(-3.84%)

Nikkei 225

10,568.52 84.39
(0.80%)

Forex

USD-INR

91.48 0.43
(0.47%)

EUR-INR

107.28 -0.27
(-0.25%)

GBP-INR

122.62 -0.09
(-0.07%)

JPY-INR

0.58 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

443.742985

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

24.58

836.83

EPS(TTM)

Face Value()

Div & Yield %

63.45

0.04

Back

G G Engineering reports standalone net loss of Rs 0.28 crore in the September 2025 quarter

Oct 14,2025

Net loss of G G Engineering reported to Rs 0.28 crore in the quarter ended September 2025 as against net profit of Rs 11.42 crore during the previous quarter ended September 2024. Sales rose 18.31% to Rs 42.33 crore in the quarter ended September 2025 as against Rs 35.78 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	42.33	35.78	18
OPM %	-1.16	37.09	-
PBDT	0.86	14.24	-94
PBT	0.75	14.11	-95
NP	-0.28	11.42	PL

79,116.19 -1,122.66 ( -1.40%)

48,521.56 -404.23 (-0.83%)

6,836.74 -65.88 (-0.95%)

54,115.64 -2,163.41 (-3.84%)

10,568.52 84.39 (0.80%)

91.48 0.43 (0.47%)

107.28 -0.27 (-0.25%)

122.62 -0.09 (-0.07%)

0.58 0.00 (-0.14%)